Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLO | LCTX | AUTL | ||
| Company | Allogene Therapeutics Inc | Lineage Cell Therapeutics Inc | Autolus Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 1.7000 | 1.6900 | 1.4300 | ||
| High | 1.7200 | 1.7134 | 1.4550 | ||
| Low | 1.6000 | 1.6500 | 1.4000 | ||
| Latest | 1.6100 | 1.6500 | 1.4400 | ||
| Change | -0.0900 | -0.0500 | +0.0200 | ||
| % Change | -5.29% | -2.94% | +1.41% | ||
| Volume | 5,620,000 | 697,104 | 2,440,300 | ||
| 20-Day Average Volume | 4,115,025 | 1,225,845 | 2,756,630 | ||
| Previous Close | 1.7000 | 1.7000 | 1.4200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4675 | 1.6965 | 1.7220 | ||
| 20-Day Raw Stochastic | 53.85% | 28.85% | 13.70% | ||
| 20-Day Relative Strength | 58.10 | 47.31 | 43.36 | ||
| Weighted Alpha | +11.84 | +127.34 | -37.78 | ||
| Today's Opinion | 100% Buy | 48% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 48% Buy | 40% Sell | ||
| Last Month's Opinion | 72% Buy | 56% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.05% since 01/08/26 | -6.25% since 01/08/26 | -24.61% since 01/08/26 | ||
| Low | 1.6000 on 01/15/26 | 1.6350 on 01/12/26 | 1.3400 on 01/14/26 | ||
| High | 1.8800 on 01/09/26 | 1.7850 on 01/12/26 | 1.9700 on 01/09/26 | ||
| 1-Month | |||||
| %Chg | +9.52% since 12/15/25 | -4.07% since 12/15/25 | -11.11% since 12/15/25 | ||
| Low | 1.2950 on 12/30/25 | 1.5750 on 12/30/25 | 1.3400 on 01/14/26 | ||
| High | 1.8800 on 01/09/26 | 1.8350 on 01/07/26 | 2.0700 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +26.77% since 10/15/25 | -8.84% since 10/15/25 | -16.28% since 10/15/25 | ||
| Low | 1.0400 on 11/07/25 | 1.5300 on 11/07/25 | 1.2000 on 11/21/25 | ||
| High | 1.8800 on 01/09/26 | 2.0900 on 11/03/25 | 2.0700 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +29.84% since 07/15/25 | +65.00% since 07/15/25 | -42.17% since 07/15/25 | ||
| Low | 0.9842 on 08/07/25 | 0.9296 on 07/22/25 | 1.2000 on 11/21/25 | ||
| High | 1.8800 on 01/09/26 | 2.0900 on 11/03/25 | 2.7000 on 07/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 382,041 | 391,558 | 377,923 | ||
| Shares Outstanding, K | 224,730 | 230,328 | 266,143 | ||
| Annual Sales | 20,000 | 9,500,000 | 10,120,000 | ||
| Annual Net Income | -257,590,000 | -18,610,000 | -220,660,000 | ||
| Last Quarter Sales | 0 | 3,680,000 | 21,190,000 | ||
| Last Quarter Net Income | -41,400,000 | -29,780,000 | -79,120,000 | ||
| 60-Month Beta | 0.51 | 1.74 | 2.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 11/06/25 | -0.13 on 11/06/25 | -0.30 on 11/12/25 | ||
| Latest Earnings Date | 03/12/26 | 03/09/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||